Science
Mechanism of Action
Ruscogenin exerts its anti-inflammatory effects by modulating crucial cellular signaling pathways. Its mode of action involves the suppression of leukocyte migration through the regulation of specific protein and mRNA expression. Furthermore, it directly inhibits the activation of nuclear factor-kappaB (NF-κB) and the expression of intercellular adhesion molecule-1 (ICAM-1), both of which are induced by the pro-inflammatory cytokine TNF-alpha, thereby reducing the inflammatory cascade at a molecular level.
Research
Clinical Evidence
High confidenceN/A
Key findings
- 01 Demonstrated concentration-dependent inhibition of leukocyte adhesion to TNF-alpha-injured human umbilical vein endothelial cells (ECV304).
- 02 Significantly suppressed zymosan A-evoked peritoneal total leukocyte migration in mice in a dose-dependent manner.
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Optimal solubility in DMSO can be compromised by moisture contamination. For in-vivo applications, it forms a homogeneous suspension when formulated with CMC-Na solution.
Safety
Safety Profile
The Cosmetic Ingredient Review (CIR) has not yet formally assessed Ruscogenin's safety. No specific maximum concentration has been publicly established.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Ruscogenin is a valuable anti-inflammatory ingredient for soothing irritated skin and reducing redness, effectively targeting cellular inflammatory pathways through its precise mechanism of action.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources